Concord Biotech Ltd. IPO

The company is a leading India-based biopharma company specializing in fermentation-based APIs for immunosuppressants and oncology. With a significant global market share, the company supply to over 70 countries, including regulated markets. Its sustainable manufacturing capabilities and focus on therapeutic areas like immunology and oncology drive its success in the dynamic biopharma industry.

Open Demat Account

Concord Biotech Ltd. IPO Details

Check out the issue details for Concord Biotech Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 741

Price Band

₹ 705 - 741

Issue Size

1,551.00 Cr.

Issue Type

Book Built

Open

2023-08-04

Close

2023-08-08

Listing price

₹ 900.05

Listing Gain

21.46%

Listing Date

2023-08-18

CMP

₹ 1343.3

Current Return

81.28%

Concord Biotech Ltd. News

Concord Biotech informs about updates 10 Jun 2026, 11:08AM Concord Biotech zooms after getting USFDA’s nod for Tofacitinib Tablets10 Jun 2026, 10:50AM Concord Biotech gets USFDA’s nod for Tofacitinib Tablets10 Jun 2026, 10:40AM Concord Biotech soars on getting USFDA nod for Mycophenolate Mofetil for Oral Suspension3 Jun 2026, 10:13AM Concord Biotech gets USFDA nod for Mycophenolate Mofetil for Oral Suspension3 Jun 2026, 10:00AM Concord Biotech informs about press release30 May 2026, 4:04PM Concord Biotech - Quaterly Results30 May 2026, 12:00AM Concord Biotech informs about board meeting23 May 2026, 10:50AM Concord Biotech informs about investor conference20 Feb 2026, 10:45AM Concord Biotech informs about investor conference20 Feb 2026, 10:41AM Concord Biotech informs about board meeting 6 Feb 2026, 2:19PM Concord Biotech informs about certificate6 Jan 2026, 12:14PM Concord Biotech informs about closure of trading window26 Dec 2025, 10:12AM Concord Biotech informs about transcripts of earnings call 19 Nov 2025, 11:29AM Concord Biotech informs about analyst meet outcome 15 Nov 2025, 11:46AM Concord Biotech - Quaterly Results14 Nov 2025, 12:00AM Concord Biotech informs about board meeting 8 Nov 2025, 10:46AM Concord Biotech completes NAFDAC inspection at Valthera facility in Gujarat8 Oct 2025, 2:39PM Concord Biotech informs about successful completion of NAFDAC inspection8 Oct 2025, 12:20PM EU-GMP authorities conduct inspection at Concord Biotech’s API facility in Limbassi 21 Aug 2025, 3:58PM

Company Financials

You can get the following financial statements of Concord Biotech Ltd. as of now.

The details about the Concord Biotech IPO is as:

  • The issue size of the Concord Biotech IPO is 1551 Cr.
  • The price band for Concord Biotech IPO is Rs 705 to Rs 741.
  • The shares of Concord Biotech IPO will list on 18th August 2023.
  • The latest tentative GMP of Concord Biotech IPO is Rs 150.
  • The shares of Concord Biotech IPO is subscribed 24.87 Times as of 8th August 2023.

 

Concord Biotech IPO Valuation

The approx valuation of Concord Biotech IPO based on its price band and RHP/DRHP (prospectus) is:

Particulars Value
Upper Price Band Rs 741
Existing Shares (Qty) 10.46 Cr
Market Cap 7750.86 Cr
EPS (FY23) Rs 22.95
PE Ratio 32.28x
Industry PE 35.98x

 

Concord Biotech IPO Issue Size

Concord Biotech IPO issue size is 1551 Cr.

Issue Amount
Fresh Issue 0 Cr
Offer For Sale 1551 Cr

 

Concord Biotech IPO Market Lot

An Individual can apply for a minimum 1 lot of 20 shares and a maximum of 13 lots of 260 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 20 Rs 14,820
 Maximum 13 260 Rs 1,92,660

 

Concord Biotech IPO Offer

The shares of Concord Biotech IPO is subscribed 24.87 Times as of 8th August 2023. The category-wise shares subscribed are as follows:

Category % Offered Subscription
Qualified Institutional Maximum 50% 67.67 Times
Non-Institutional Minimum 15% 16.99 Times
Retail Individual Minimum 35% 3.78 Times
Employee 10000 Shares 24.48 Times
Total   24.87 Times

 

Concord Biotech IPO Grey Market Premium

As on GMP (Tentative)
6 August 2023 Rs 150
7 August 2023 Rs 200
8  August 2023 Rs 160
9 August 2023 Rs 140
10 August 2023 Rs 160
13  August 2023 Rs 160
14  August 2023 Rs 150

Concord Biotech IPO GMP is purely for informational purposes and invest in an IPO after thoroughly researching on your own.

Find below the dates for Concord Biotech Ltd IPO

Schedule Date
Basis of Allotment 11 August 2023
Refunds 14 August 2023
Credit to Demat Account 17 August 2023
IPO Listing Date 18 August 2023

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 616.94 712.93 853.17 1016.94 1200.09
Total Expenditure 289.01 439.01 504.59 584.75 693.24
Operating Profit 327.93 273.93 348.58 432.19 506.84
Other Income 13.81 23.42 35.31 33.78 44.45
Interest 1.05 6.13 9.8 3.18 1.04
Depreciation 27.52 50.05 54.03 53.59 54.37
Exceptional Items 0 0 0 0 0
Profit Before Tax 313.17 241.16 320.05 409.19 495.88
Provision for Tax 77.83 62.59 81.93 104.46 122.91
Net Profit 235.29 178.57 238.13 304.73 372.96
Adjusted EPS (Rs.) 2.25 1.71 2.28 2.91 3.57

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 9.51 9.51 10.46 10.46 10.46
Total Reserves 990.16 1097.65 1281.52 1514.79 1802.18
Borrowings 56.25 31.25 6.24 0 0
Other N/C liabilities 151.37 212.23 25.9 31.91 37.47
Current liabilities 105.74 151.89 190.53 142.16 184.06
Total Liabilities 1313.03 1502.53 1514.65 1699.32 2034.18
Assets
Net Block 546.22 572.98 592.98 575.32 794.69
Capital WIP 17.95 74.16 172.7 211.48 50.13
Intangible WIP 0 0 0 0 0.53
Investments 0.67 0.92 0.79 0.67 18.65
Loans & Advances 140.61 220.99 11.61 12.81 12.01
Other N/C Assets 0.45 0.82 8.87 2.81 22.93
Current Assets 607.15 632.67 727.7 896.23 1135.24
Total Assets 1313.03 1502.53 1514.65 1699.32 2034.18
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Other Income 9.38 13.68 13.43 10.08 15.54
Profit Before Tax 185.09 57.24 85.52 90.3 118.38
Tax 43.16 14.67 22.62 22.51 28.36
Profit After Tax 141.94 42.57 62.9 67.78 90.02
Adjusted EPS (Rs) 13.57 4.07 6.01 6.48 8.6

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2026 44.08 0
Dec 2025 44.08 0
Sep 2025 44.08 0
Jun 2025 44.08 0
Mar 2025 44.08 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 313.17 241.16 320.05 409.19 495.88
Adjustment 17.59 49.16 48.51 40.8 28.82
Changes in Assets & Liabilities -88.77 -22.06 -52.29 -81.18 -170.76
Tax Paid -75.18 -60.78 -70.28 -103.35 -109.42
Operating Cash Flow 166.81 207.47 246 265.47 244.52
Investing Cash Flow -195.2 -111.79 -157.95 -154.61 -159.99
Financing Cash Flow 31.12 -100.16 -85.22 -99.21 -98.77
Net Cash Flow 2.74 -4.48 2.83 11.64 -14.24
X